About Us

Meet Prolong Pharmaceuticals

Prolong Pharmaceuticals is a clinical-stage biopharmaceutical leader focused on advancing innovative therapies to address complex diseases and critical unmet medical needs.

Headquartered in South Plainfield, New Jersey, Prolong is committed to identifying, developing, and commercializing novel biologics treat diseases and their associated comorbidities, improving patient outcomes while reducing healthcare burden and mortality.
Our Origin

Founded in 2005 as a research laboratory, Prolong has evolved into a mature, privately held biotechnology company with an active clinical development pipeline and large-scale cGMP manufacturing capabilities.

Our founders were among the pioneers of PEGylation, contributing to the first regulatory approval of a PEGylated protein therapeutic (Adagen®, Enzon, 1990).  
Since then, PEGylation has become a foundational drug delivery technology, enabling a broad range of therapies designed to improve outcomes in diseases such as hepatitis, kidney disease, and other serious conditions.
meet the team
transforming
lives
Innovating health
transforming lives
transforming
lives

Our Scientific Foundation - Transformative Medicine through Innovative Design

Building on decades of PEGylation expertise, Prolong developed PEGfinity™, a proprietary platform designed to enhance protein therapeutics through advanced engineering and precision optimization.  By integrating PEGylation with in-silico analytical methods, PEGfinity™ enables: Comprehensive and efficient protein modification; Rapid generation of optimized drug candidates; Iterative structure–function analysis tailored to each protein and clinical indication  
learn more about sanguinate

Be part of Our journey

Join us in advancing treatments for severe and life-threatening conditions.
call us
or
email our team
Address
300 Corporate Court, Suite B
South Plainfield, NJ 07080 USA
Phone
(908) 444-4660 direct
(908) 444-4661 fax
Email
info@prolongpharma.com
About Us
Meet ProlongManagement TeamMedical Advisory BoardOur Investors
Sanguinate®
PipelineHow it WorksGlobal Strokes FactsClinical Trials
Resources
PublicationsConferencesNewsReferences
Legal
Copyright Notice
Terms & Conditions
Privacy Policy
Expanded Access Policy
Prolong Pharmaceuticals, LLC does not provide any investigational drugs to patients outside of participation in an active clinical trial. For more information on our ongoing clinical trials, please contact info@prolongpharma.com.